These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33008028)

  • 41. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model.
    Breshears LM; Edwards VL; Ravel J; Peterson ML
    BMC Microbiol; 2015 Dec; 15():276. PubMed ID: 26652855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials.
    Moncla BJ; Hillier SL
    Sex Transm Dis; 2005 Aug; 32(8):491-4. PubMed ID: 16041251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of vaginal lactobacilli from HIV-negative and HIV-positive Indian women and their association with genital HIV-1 shedding.
    Mane A; Angadi M; Vidhate P; Bembalkar S; Khan I; Bichare S; Ghate M; Thakar M
    J Med Microbiol; 2017 Oct; 66(10):1471-1475. PubMed ID: 28945188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lactobacillus crispatus accelerates re-epithelialization in vaginal epithelial cell line MS74.
    Takada K; Komine-Aizawa S; Kuramochi T; Ito S; Trinh QD; Pham NTK; Sasano M; Hayakawa S
    Am J Reprod Immunol; 2018 Sep; 80(3):e13027. PubMed ID: 30144195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular epidemiological study of vertical transmission of vaginal Lactobacillus species from mothers to newborn infants in Japanese, by arbitrarily primed polymerase chain reaction.
    Matsumiya Y; Kato N; Watanabe K; Kato H
    J Infect Chemother; 2002 Mar; 8(1):43-9. PubMed ID: 11957119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of Toxic Shock Syndrome-Associated
    Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
    Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Selective Inhibition of Lactobacillus iners by
    Nilsen T; Swedek I; Lagenaur LA; Parks TP
    Appl Environ Microbiol; 2020 Oct; 86(20):. PubMed ID: 32801180
    [No Abstract]   [Full Text] [Related]  

  • 48. Characterisation of cell membrane interaction mechanisms of antimicrobial peptides by electrical bilayer recording.
    Priyadarshini D; Ivica J; Separovic F; de Planque MRR
    Biophys Chem; 2022 Feb; 281():106721. PubMed ID: 34808479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Preliminary examination of a LB-H2O2 substance that inhibit Neisseria gonorrhea growth].
    Zheng H; Cao J; Jin H; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):379-83. PubMed ID: 12567437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae.
    Kiattiburut W; Zhi R; Lee SG; Foo AC; Hickling DR; Keillor JW; Goto NK; Li W; Conlan W; Angel JB; Wang G; Tanphaichitr N
    Hum Reprod; 2018 Dec; 33(12):2175-2183. PubMed ID: 30357408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae.
    Lee SG; Kiattiburut W; Khongkha T; Schinkel SCB; Lunn Y; Decker AP; Mohammadi A; Vera-Cruz A; Misra A; Angel JB; Anderson DJ; Baker M; Kaul R; Wang G; Tanphaichitr N
    Hum Reprod; 2022 Oct; 37(11):2503-2517. PubMed ID: 36053257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of vaginal microbes and classification of the vaginal microbiome.
    Zhu B; Spaine KM; Edupuganti L; Matveyev A; Serrano MG; Buck GA
    bioRxiv; 2023 Aug; ():. PubMed ID: 37645743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent.
    Vera-Cruz A; Tanphaichitr N; Angel JB
    Clin Invest Med; 2021 Oct; 44(3):E64-71. PubMed ID: 34600462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract.
    St Amant DC; Valentin-Bon IE; Jerse AE
    Infect Immun; 2002 Dec; 70(12):7169-71. PubMed ID: 12438404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comprehensive investigation of the medicinal efficacy of antimicrobial fusion peptides expressed in probiotic bacteria for the treatment of pan drug-resistant (PDR) infections.
    Safarpour-Dehkordi M; Chabok O; Asgari M; Khademi R; Doosti A
    Arch Microbiol; 2024 Feb; 206(3):93. PubMed ID: 38329629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Vaginal Microbiome of Nonhuman Primates Can Be Only Transiently Altered to Become
    Langner CA; Ortiz AM; Flynn JK; Kendall H; Lagenaur LA; Brenchley JM
    Microbiol Spectr; 2021 Dec; 9(3):e0107421. PubMed ID: 34756073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37.
    Bergman P; Johansson L; Asp V; Plant L; Gudmundsson GH; Jonsson AB; Agerberth B
    Cell Microbiol; 2005 Jul; 7(7):1009-17. PubMed ID: 15953032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First Steps towards the Pharmaceutical Development of Ovules Containing Lactobacillus Strains: Viability and Antimicrobial Activity as Basic First Parameters in Vaginal Formulations.
    Camilletti AL; Ruíz FO; Pascual LM; Barberis IL
    AAPS PharmSciTech; 2018 Feb; 19(2):886-895. PubMed ID: 29043604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.